Chicago, IL, United States of America

Wrickban Mazumdar

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Indiana University, University of Illinois. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wrickban Mazumdar. Retrieved from https://idiyas.com/inventor/wrickban-mazumdar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Wrickban Mazumdar - Pioneering Advances in Pharmaceutical Research

Introduction: Meet Wrickban Mazumdar, a talented inventor based in Chicago, IL, with a passion for developing innovative solutions in the field of pharmaceuticals.

Latest Patents: Wrickban Mazumdar has recently been granted two patents for his groundbreaking work on Nicotinamide phosphoribosyltransferase ('NAMPT') inhibitors. These compounds have shown promising potential in treating and preventing diseases such as pulmonary arterial hypertension ('PAH').

Career Highlights: With a rich academic background, Wrickban Mazumdar has contributed his expertise to esteemed institutions such as Indiana University and the University of Illinois. His dedication to research and development has led to the successful filing of multiple patents in the pharmaceutical industry.

Collaborations: Throughout his career, Wrickban Mazumdar has collaborated with esteemed colleagues such as Tom G Driver and Roberto F Machado. Together, they have worked on cutting-edge projects that have the potential to revolutionize the field of pharmaceuticals.

Conclusion: Wrickban Mazumdar is a visionary inventor whose work is paving the way for new advancements in pharmaceutical research. His innovative approach and dedication to improving healthcare have earned him recognition as a leading figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…